Hartman John T. 4
4 · EQUIFAX INC · Filed Feb 25, 2020
Insider Transaction Report
Form 4
EQUIFAX INCEFX
Hartman John T.
Pres-Intl
Transactions
- Award
Common Stock
2020-02-21+1,567→ 20,645 total - Award
Stock Option/Right to Buy
2020-02-21+5,472→ 5,472 totalExercise: $175.48Exp: 2026-02-21→ Common Stock (5,472 underlying) - Sale
Common Stock
2020-02-21$159.83/sh−144$23,016→ 20,501 total - Sale
Common Stock
2020-02-21$160.48/sh−222$35,627→ 20,279 total - Award
Stock Option/Right to Buy
2020-02-21+6,904→ 6,904 totalExercise: $191.44Exp: 2026-02-21→ Common Stock (6,904 underlying)
Footnotes (6)
- [F1]Annual equity grant pursuant to the Company's long-term incentive plan. The award of restricted stock units vests 100% on 2/21/2023.
- [F2]Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date.
- [F3]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 20, 2019.
- [F4]The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $159.15 to $160.14, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided.
- [F5]The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $160.16 to $160.60, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided.
- [F6]Annual equity grant pursuant to the Company's long-term incentive plan. The option vests in three equal annual increments beginning 2/21/2021.